Literature DB >> 18447641

Whole-blastocyst culture followed by laser drilling technology enhances the efficiency of inner cell mass isolation and embryonic stem cell derivation from good- and poor-quality mouse embryos: new insights for derivation of human embryonic stem cell lines.

J L Cortes1, L Sánchez, P Catalina, F Cobo, C Bueno, A Martínez-Ramirez, A Barroso, C Cabrera, G Ligero, R Montes, R Rubio, A Nieto, P Menendez.   

Abstract

The optimization of human embryonic stem (hES) cell line derivation methods is challenging because many worldwide laboratories have neither access to spare human embryos nor ethical approval for using supernumerary human embryos for hES cell derivation purposes. Additionally, studies performed directly on human embryos imply a waste of precious human biological material. In this study, we developed a new strategy based on the combination of whole-blastocyst culture followed by laser drilling destruction of the trophoectoderm for improving the efficiency of inner cell mass (ICM) isolation and ES cell derivation using murine embryos. Embryos were divided into good- and poor-quality embryos. We demonstrate that the efficiency of both ICM isolation and ES cell derivation using this strategy is significantly superior to whole-blastocyst culture or laser drilling technology itself. Regardless of the ICM isolation method, the ES cell establishment depends on a feeder cell growth surface. Importantly, this combined methodology can be successfully applied to poor-quality blastocysts that otherwise would not be suitable for laser drilling itself nor immunosurgery in an attempt to derive ES cell lines due to the inability to distinguish the ICM. The ES cell lines derived by this combined method were characterized and shown to maintain a typical morphology, undifferentiated phenotype, and in vitro and in vivo three germ layer differentiation potential. Finally, all ES cell lines established using either technology acquired an aneuploid karyotype after extended culture periods, suggesting that the method used for ES cell derivation does not seem to influence the karyotype of the ES cells after extended culture. This methodology may open up new avenues for further improvements for the derivation of hES cells, the majority of which are derived from frozen, poor-quality human embryos.

Entities:  

Mesh:

Year:  2008        PMID: 18447641     DOI: 10.1089/scd.2007.0157

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  11 in total

1.  Derivation, characterization and differentiation of a new human embryonic stem cell line from a Chinese hatched blastocyst assisted by a non-contact laser system.

Authors:  Rongrong Wu; Chenming Xu; Fan Jin; Zhou Tan; Bin Gu; Liangbiao Chen; Xing Yao; Ming Zhang
Journal:  Hum Cell       Date:  2010-10-01       Impact factor: 4.174

2.  Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos.

Authors:  Adeleh Taei; Hamid Gourabi; Ali Seifinejad; Mehdi Totonchi; Ebrahim Shahbazi; Mojtaba Rezazadeh Valojerdi; Poopak Eftekhari; Leila Karimian; Hossein Baharvand
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

3.  Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.

Authors:  Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

4.  Laser-mediated cell ablation during post-implantation mouse development.

Authors:  Jesse R Angelo; Kimberly D Tremblay
Journal:  Dev Dyn       Date:  2013-09-02       Impact factor: 3.780

5.  Improved efficiency of microsurgical enucleated tripronuclear zygotes development and embryonic stem cell derivation by supplementing epidermal growth factor, brain-derived neurotrophic factor, and insulin-like growth factor-1.

Authors:  Yong Fan; Rong Li; Jin Huang; Hong-Cui Zhao; Ting Ding; Xiaofang Sun; Yang Yu; Jie Qiao
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

Review 6.  Versatile cell ablation tools and their applications to study loss of cell functions.

Authors:  Fengming Liu; Shen Dai; Dechun Feng; Xiao Peng; Zhongnan Qin; Alison C Kearns; Wenfei Huang; Yong Chen; Süleyman Ergün; Hong Wang; Jay Rappaport; Elizabeth C Bryda; Anand Chandrasekhar; Bertal Aktas; Hongzhen Hu; Sulie L Chang; Bin Gao; Xuebin Qin
Journal:  Cell Mol Life Sci       Date:  2019-07-29       Impact factor: 9.261

7.  Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system.

Authors:  Behrouz Aflatoonian; Ludmila Ruban; Shamsul Shamsuddin; Duncan Baker; Peter Andrews; Harry Moore
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-12       Impact factor: 2.416

8.  Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications.

Authors:  Shelly E Tannenbaum; Tikva Tako Turetsky; Orna Singer; Einat Aizenman; Sophie Kirshberg; Nili Ilouz; Yaniv Gil; Yael Berman-Zaken; Temima Schnitzer Perlman; Nitshia Geva; Ora Levy; Daniel Arbell; Alex Simon; Assaf Ben-Meir; Yoel Shufaro; Neri Laufer; Benjamin E Reubinoff
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

9.  No relationship between embryo morphology and successful derivation of human embryonic stem cell lines.

Authors:  Susanne Ström; Kenny Rodriguez-Wallberg; Frida Holm; Rosita Bergström; Linda Eklund; Anne-Marie Strömberg; Outi Hovatta
Journal:  PLoS One       Date:  2010-12-31       Impact factor: 3.240

10.  Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Authors:  Verónica Ramos-Mejía; Rosa Montes; Clara Bueno; Verónica Ayllón; Pedro J Real; René Rodríguez; Pablo Menendez
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.